Copyright © Inderes 2011 - present. All rights reserved.
  • Senaste
  • Börs
    • Morning Review
    • Aktiejämförelse
    • Börskalender
    • Utdelningskalender
    • Aktieanalys
    • Artiklar
    • Insider Transactions
  • InderesTV
  • Portfölj
  • Forum
  • Premium
  • Femme
  • Nora AI
  • Learn
    • Investing School
    • Q&A
    • Analysis School
  • Om oss
    • Bolag under bevakning
    • Teamet

Du verkar använda en bredare skärm. Vill du aktivera en bredare visningsupplevelse på denna sida?

Ascelia Pharma - Podcast with Deputy CEO Julie Waras Brogren and CSO Andreas Norlin

Av Claus ThestrupCEO, Sweden
Ascelia Pharma

We have sat down with Ascelia Pharma Deputy CEO Julie Waras Brogren and CSO Andreas Norlin. In this podcast, we are covering the following topics:

Warrant TO1 - Exercise period ongoing:  Subscription period, price, and price calculation. What are gross proceeds at 100% participation?

Feedback from presenting Orviglance abstracts at scientific conferences: RSNA, Society of Abdominal Radiology Congress, ESGAR, ISPOR. What kind of feedback do you receive from the scientific community ie. clinicians, physicians, and KOL?  Do payers, policymakers, healthcare providers, patient organizations, and industry players participate?

Discussions with the FDA: Ascelia Pharma received a positive outcome from the FDA and are ready to file their NDA in mid-2025. What is the format when you discuss with the FDA?

Disclaimer: HC Andersen Capital receives payment from Ascelia Pharam for a Corporate Visibility/Digital IR subscription agreement. /Claus Thestrup, 11.24 AM, 11 April 2025.

Recent videos

Talenom - Planned demerger and strategies of Talenom and Easor
18.12.2025 klo 12.00 Talenom
Conference call with Fabege´s new CEO Bent Oustad
18.12.2025 klo 11.00 Fabege
Investing in the life science sector
18.12.2025 klo 08.47
Life Science Companies as Investments | Life Science Night Dec. 9, 2025
16.12.2025 klo 09.30 Aiforia Technologies
Truecaller, Webcast, Press Conference, 2025
15.12.2025 klo 14.00 Truecaller
Titta på alla videos
Följ oss på våra kanaler i social media
  • Inderes Forum
  • Youtube
  • Facebook
  • Instagram
  • X (Twitter)
  • Tiktok
  • Linkedin
Ta kontakt
  • info@inderes.fi
  • +358 10 219 4690
  • Porkkalankatu 5
    00180 Helsinki
Inderes
  • Om oss
  • Teamet
  • Jobba hos oss
  • Inderes som en investering
  • Tjänster för börsbolag
Vår plattform
  • FAQ
  • Servicevillkor
  • Integritetspolicy
  • Disclaimer
Inderes disclaimer gällande utförda aktieanalyser kan läsas här. För mer detaljerad information över de aktier som aktivt bevakas av Inderes, vänligen se respektive bolags bolagsspecifika sida på Inderes webbplats. © Inderes Oyj. Alla rättigheter förbehållna.